Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/158950
The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.
Subject
Subject (English)
Citation
Citation
DE LA TORRE, Beatriz G. and ALBERICIO PALOMERA, Fernando. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules. Molecules. 2017. Vol. 22, num. 3, pags. 368. ISSN 1420-3049. [consulted: 6 of June of 2026]. Available at: https://hdl.handle.net/2445/158950